Cooper Retained Earnings (Accumulated Deficit) 2010-2024 | COO
Cooper retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Cooper retained earnings (accumulated deficit) for the quarter ending July 31, 2024 were $7.151B, a 5.29% increase year-over-year.
- Cooper retained earnings (accumulated deficit) for 2023 were $6.876B, a 4.42% increase from 2022.
- Cooper retained earnings (accumulated deficit) for 2022 were $6.585B, a 6.17% increase from 2021.
- Cooper retained earnings (accumulated deficit) for 2021 were $6.202B, a 90.14% increase from 2020.
Cooper Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$6,876 |
| 2022 |
$6,585 |
| 2021 |
$6,202 |
| 2020 |
$3,262 |
| 2019 |
$3,026 |
| 2018 |
$2,576 |
| 2017 |
$2,434 |
| 2016 |
$2,046 |
| 2015 |
$1,779 |
| 2014 |
$1,579 |
| 2013 |
$1,312 |
| 2012 |
$1,019 |
| 2011 |
$773 |
| 2010 |
$601 |
| 2009 |
$490 |
Cooper Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024-07-31 |
$7,151 |
| 2024-04-30 |
$7,046 |
| 2024-01-31 |
$6,957 |
| 2023-10-31 |
$6,876 |
| 2023-07-31 |
$6,792 |
| 2023-04-30 |
$6,708 |
| 2023-01-31 |
$6,668 |
| 2022-10-31 |
$6,585 |
| 2022-07-31 |
$6,519 |
| 2022-04-30 |
$6,423 |
| 2022-01-31 |
$6,296 |
| 2021-10-31 |
$6,202 |
| 2021-07-31 |
$6,092 |
| 2021-04-30 |
$5,478 |
| 2021-01-31 |
$5,360 |
| 2020-10-31 |
$3,262 |
| 2020-07-31 |
$3,181 |
| 2020-04-30 |
$3,127 |
| 2020-01-31 |
$3,115 |
| 2019-10-31 |
$3,026 |
| 2019-07-31 |
$2,905 |
| 2019-04-30 |
$2,787 |
| 2019-01-31 |
$2,664 |
| 2018-10-31 |
$2,576 |
| 2018-07-31 |
$2,471 |
| 2018-04-30 |
$2,371 |
| 2018-01-31 |
$2,310 |
| 2017-10-31 |
$2,434 |
| 2017-07-31 |
$2,346 |
| 2017-04-30 |
$2,243 |
| 2017-01-31 |
$2,139 |
| 2016-10-31 |
$2,046 |
| 2016-07-31 |
$1,990 |
| 2016-04-30 |
$1,903 |
| 2016-01-31 |
$1,829 |
| 2015-10-31 |
$1,779 |
| 2015-07-31 |
$1,743 |
| 2015-04-30 |
$1,699 |
| 2015-01-31 |
$1,639 |
| 2014-10-31 |
$1,579 |
| 2014-07-31 |
$1,548 |
| 2014-04-30 |
$1,461 |
| 2014-01-31 |
$1,382 |
| 2013-10-31 |
$1,312 |
| 2013-07-31 |
$1,254 |
| 2013-04-30 |
$1,167 |
| 2013-01-31 |
$1,092 |
| 2012-10-31 |
$1,019 |
| 2012-07-31 |
$947 |
| 2012-04-30 |
$881 |
| 2012-01-31 |
$826 |
| 2011-10-31 |
$773 |
| 2011-07-31 |
$716 |
| 2011-04-30 |
$680 |
| 2011-01-31 |
$644 |
| 2010-10-31 |
$601 |
| 2010-07-31 |
$552 |
| 2010-04-30 |
$514 |
| 2010-01-31 |
$510 |
| 2009-10-31 |
$490 |
| 2009-07-31 |
$470 |
| 2009-04-30 |
$449 |
| 2009-01-31 |
$425 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.898B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
